Today’s cyclodextrin is yet another fascinating patent from Beren Therapeutics, and my old colleague, Gábor Benkovics PhD on HPBCD.
This time they show methods of isomerically purifying a mixture of hydroxypropyl-β-cyclodextrins, with the goal of creating safer and better active ingredients from “common” cyclodextrins.
Way to go guys!
Beren’s former patents detailed the use of HPBCD in various hashtag#cardiovascular conditions involving hashtag#cholesterol homeostasis such as hashtag#atherosclerosis or familiar hypercholesterolemia.
